Review ArticleReview

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma

Kim Teresa, Rodabe N. Amaria, Christine Spencer, Alexandre Reuben, Zachary A. Cooper and Jennifer A. Wargo
Cancer Biology & Medicine December 2014, 11 (4) 237-246; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.002

Article Information

vol. 11 no. 4 237-246
DOI 
https://doi.org/10.7497/j.issn.2095-3941.2014.04.002
Published By 
Cancer Biology & Medicine
History 
  • Received September 9, 2014
  • Accepted October 13, 2014
  • Published online December 1, 2014.
Copyright & Usage 
Copyright: © 2014, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Kim Teresa1,2,*,
  2. Rodabe N. Amaria3,*,
  3. Christine Spencer4,
  4. Alexandre Reuben5,
  5. Zachary A. Cooper⇑4,5 and
  6. Jennifer A. Wargo⇑4,5
  1. 1Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA
  2. 2Harvard Medical School, Boston, MA 02115, USA
  3. 3Department of Melanoma Medical Oncology
  4. 4Department of Genomic Medicine
  5. 5Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
  1. Correspondence to: Zachary A. Cooper and Jennifer A. Wargo E-mail: zcooper{at}mdanderson.org and jwargo{at}mdanderson.org
View Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords